Cargando…
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
INTRODUCTION: At least four major categories of invasive breast cancer that are associated with different clinical outcomes have been identified by gene expression profiling: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) and basal-like. However, the prevalence of these phenot...
Autores principales: | Tamimi, Rulla M, Baer, Heather J, Marotti, Jonathan, Galan, Mark, Galaburda, Laurie, Fu, Yineng, Deitz, Anne C, Connolly, James L, Schnitt, Stuart J, Colditz, Graham A, Collins, Laura C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575540/ https://www.ncbi.nlm.nih.gov/pubmed/18681955 http://dx.doi.org/10.1186/bcr2128 |
Ejemplares similares
-
Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case–control study
por: Tamimi, Rulla M, et al.
Publicado: (2005) -
Androgen Receptor Expression in Breast Cancer in Relation to Molecular Phenotype: Results from the Nurses’ Health Study
por: Collins, Laura C., et al.
Publicado: (2011) -
Luminal B breast tumors are not HER2 positive – authors' response
por: Tamimi, Rulla M, et al.
Publicado: (2008) -
Columnar cell lesions and subsequent breast cancer risk: a nested case-control study
por: Aroner, Sarah A, et al.
Publicado: (2010) -
The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin
por: Schnitt, Stuart J
Publicado: (2009)